Evolution of the SARS‐CoV‐2 omicron variants BA.1 to BA.5: Implications for immune escape and transmission

mRNA-based COVID-19 vaccine boosters induce neutralizing immunity against SARS-CoV-2 Omicron variant

(2022) Wilfredo F. Garcia-Beltran et al.   CELL

SARS-CoV-2 Omicron-B.1.1.529 leads to widespread escape from neutralizing antibody responses

(2022) Wanwisa Dejnirattisai et al.   CELL

Omicron Genetic and Clinical Peculiarities That May Overturn SARS-CoV-2 Pandemic: A Literature Review

(2022) Giorgio Tiecco et al.   INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

Association Between 3 Doses of mRNA COVID-19 Vaccine and Symptomatic Infection Caused by the SARS-CoV-2 Omicron and Delta Variants

(2022) Emma K. Accorsi et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Estimates of SARS-CoV-2 Omicron Variant Severity in Ontario, Canada

(2022) Ana Cecilia Ulloa et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Omicron Variant (B.1.1.529): Infectivity, Vaccine Breakthrough, and Antibody Resistance

(2022) Jiahui Chen et al.   Journal of Chemical Information and Modeling

Omicron variant of SARS‐CoV‐2: Genomics, transmissibility, and responses to current COVID‐19 vaccines

(2022) Yusha Araf et al.   JOURNAL OF MEDICAL VIROLOGY

Early assessment of the clinical severity of the SARS-CoV-2 omicron variant in South Africa: a data linkage study

(2022) Nicole Wolter et al.   LANCET

Efficacy of Antibodies and Antiviral Drugs against Covid-19 Omicron Variant

(2022) Emi Takashita et al.   NEW ENGLAND JOURNAL OF MEDICINE

Population Immunity and Covid-19 Severity with Omicron Variant in South Africa

(2022) Shabir A. Madhi et al.   NEW ENGLAND JOURNAL OF MEDICINE

Protection against the Omicron Variant from Previous SARS-CoV-2 Infection

(2022) Heba N. Altarawneh et al.   NEW ENGLAND JOURNAL OF MEDICINE

Heterologous infection and vaccination shapes immunity against SARS-CoV-2 variants

(2022) Catherine J. Reynolds et al.   SCIENCE

Neutralization of SARS-CoV-2 Omicron by BNT162b2 mRNA vaccine–elicited human sera

(2022) Alexander Muik et al.   SCIENCE

Maintenance of broad neutralizing antibodies and memory B cells 1 year post-infection is predicted by SARS-CoV-2-specific CD4+ T cell responses

(2022) Harikrishnan Balachandran et al.   Cell Reports

Are new Omicron subvariants a threat? Here’s how scientists are keeping watch

(2022) Amy Maxmen   NATURE

Protection by a Fourth Dose of BNT162b2 against Omicron in Israel

(2022) Yinon M. Bar-On et al.   NEW ENGLAND JOURNAL OF MEDICINE

Efficacy of a Fourth Dose of Covid-19 mRNA Vaccine against Omicron

(2022) Gili Regev-Yochay et al.   NEW ENGLAND JOURNAL OF MEDICINE

Neutralization of the SARS-CoV-2 Omicron BA.1 and BA.2 Variants

(2022) Jingyou Yu et al.   NEW ENGLAND JOURNAL OF MEDICINE

Structural basis of SARS-CoV-2 Omicron immune evasion and receptor engagement

(2022) Matthew McCallum et al.   SCIENCE

Covid-19: Symptomatic infection with omicron variant is milder and shorter than with delta, study reports

(2022) Jacqui Wise   BMJ-British Medical Journal

Emergence of Progressive Mutations in SARS-CoV-2 From a Hematologic Patient With Prolonged Viral Replication

(2022) Carolina Garcia-Vidal et al.   Frontiers in Microbiology

Antibody escape of SARS-CoV-2 Omicron BA.4 and BA.5 from vaccine and BA.1 serum

(2022) Aekkachai Tuekprakhon et al.   CELL

Neutralization of the SARS-CoV-2 Omicron BA.4/5 and BA.2.12.1 Subvariants

(2022) Panke Qu et al.   NEW ENGLAND JOURNAL OF MEDICINE

Adaptive immunity to SARS-CoV-2 and COVID-19

(2021) Alessandro Sette et al.   CELL

Effects of Environmental Factors on Severity and Mortality of COVID-19

(2021) Domagoj Kifer et al.   Frontiers in Medicine

Generation and transmission of interlineage recombinants in the SARS-CoV-2 pandemic

(2021) Ben Jackson et al.   CELL

Reduced neutralization of SARS-CoV-2 B.1.617 by vaccine and convalescent serum

(2021) Chang Liu et al.   CELL

The origins and potential future of SARS-CoV-2 variants of concern in the evolving COVID-19 pandemic

(2021) Sarah P. Otto et al.   CURRENT BIOLOGY

One year into the pandemic: Short-term evolution of SARS-CoV-2 and emergence of new lineages

(2021) Fernando González-Candelas et al.   INFECTION GENETICS AND EVOLUTION

Acute SARS-CoV-2 infections harbor limited within-host diversity and transmit via tight transmission bottlenecks

(2021) Katarina M. Braun et al.   PLoS Pathogens

Reactive T Cells in Convalescent COVID-19 Patients With Negative SARS-CoV-2 Antibody Serology

(2021) Sophie Steiner et al.   Frontiers in Immunology

SARS-CoV-2 variants of concern partially escape humoral but not T-cell responses in COVID-19 convalescent donors and vaccinees

(2021) Daryl Geers et al.   Science Immunology

Immunizations with diverse sarbecovirus receptor-binding domains elicit SARS-CoV-2 neutralizing antibodies against a conserved site of vulnerability

(2021) Deborah L. Burnett et al.   IMMUNITY

Antibody Response and Variant Cross-Neutralization After SARS-CoV-2 Breakthrough Infection

(2021) Timothy A. Bates et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Evidence for a mouse origin of the SARS-CoV-2 Omicron variant

(2021) Changshuo Wei et al.   Journal of Genetics and Genomics

Yearlong COVID-19 Infection Reveals Within-Host Evolution of SARS-CoV-2 in a Patient With B-Cell Depletion

(2021) Veronique Nussenblatt et al.   JOURNAL OF INFECTIOUS DISEASES

Third BNT162b2 Vaccination Neutralization of SARS-CoV-2 Omicron Infection

(2021) Ital Nemet et al.   NEW ENGLAND JOURNAL OF MEDICINE

Waning Immune Humoral Response to BNT162b2 Covid-19 Vaccine over 6 Months

(2021) Einav G. Levin et al.   NEW ENGLAND JOURNAL OF MEDICINE

Furin cleavage of the SARS-CoV-2 spike is modulated by O-glycosylation

(2021) Liping Zhang et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Where did ‘weird’ Omicron come from?

(2021) Kai Kupferschmidt   SCIENCE

Highly mutated SARS-CoV-2 Omicron variant sparks significant concern among global experts – What is known so far?

(2021) Sujan Poudel et al.   Travel Medicine and Infectious Disease

Factors affecting aerosol SARS-CoV-2 transmission via HVAC systems; a modeling study

(2021) Zachary J. Cotman et al.   PLoS Computational Biology

Broadly-Neutralizing Antibodies Against Emerging SARS-CoV-2 Variants

(2021) Lok Bahadur Shrestha et al.   Frontiers in Immunology

Targets of T Cell Responses to SARS-CoV-2 Coronavirus in Humans with COVID-19 Disease and Unexposed Individuals

(2020) Alba Grifoni et al.   CELL

Structures of Human Antibodies Bound to SARS-CoV-2 Spike Reveal Common Epitopes and Recurrent Features of Antibodies

(2020) Christopher O. Barnes et al.   CELL

A neutralizing human antibody binds to the N-terminal domain of the Spike protein of SARS-CoV-2

(2020) Xiangyang Chi et al.   SCIENCE

Antigen-Specific Adaptive Immunity to SARS-CoV-2 in Acute COVID-19 and Associations with Age and Disease Severity

(2020) Carolyn Rydyznski Moderbacher et al.   CELL

Persistence and Evolution of SARS-CoV-2 in an Immunocompromised Host

(2020) Bina Choi et al.   NEW ENGLAND JOURNAL OF MEDICINE

The Middle East Respiratory Syndrome (MERS)

(2019) Esam I. Azhar et al.   INFECTIOUS DISEASE CLINICS OF NORTH AMERICA

Nextstrain: real-time tracking of pathogen evolution

(2018) James Hadfield et al.   BIOINFORMATICS

Recombination in viruses: Mechanisms, methods of study, and evolutionary consequences

(2015) Marcos Pérez-Losada et al.   INFECTION GENETICS AND EVOLUTION